Table 2 Factors that were found to affect the long-term prognosis in IgAN patients receiving glucocorticoid medicine therapy in the univariate COX regression analyses
Characteristics | Univariate analysis | ||
|---|---|---|---|
HR | 95% CI | P value | |
Baseline | |||
 Age (years) | 1.063 | 1.014–1.115 | 0.011 |
 ALB (g/L) | 0.929 | 0.869–0.994 | 0.033 |
 eGFR (mL/min/1.73 m2) | 0.976 | 0.953–1.000 | 0.047 |
 uRBC/HP |  |  | 0.975 |
 Renal biopsy Lee’s classification, n (%) | |||
  Grade I |  |  |  |
  Grade II |  |  |  |
  Grade III |  |  |  |
  Grade IV |  |  | 0.596 |
Follow-up | |||
 Length of follow-up (months) |  |  | 0.684 |
 Non-remission (vs remission) | 5.877 | 2.031–17.006 | 0.001 |
 Relapse (vs non-relapse) | 12.602 | 1.443–110.058 | 0.022 |
 ALB g/L at month 6 | 0.844 | 0.761–0.935 | 0.001 |
 UPE at month 3 (g/day) | 1.000 | 1.000–1.001 | 0.016 |
 UPE at month 6 (g/day) | 1.000 | 1.000-1.001 | 0.043 |
 uRBC/HP at month 3 |  |  | 0.961 |
 uRBC/HP at month 6 |  |  | 0.574 |
 TA-ALB (g/L) | 0.778 | 0.663–0.913 | 0.002 |
 TA-eGFR (mL/min/1.73 m2) | 0.978 | 0.957–1.000 | 0.048 |
 TA-UPE (g/day) | 1.000 | 1.000–1.001 | 0.046 |